Immuno-related cardio-vascular adverse events associated with immuno-oncological treatments: an under-estimated threat for cancer patients.
Panuccio G, Correale P, d'Apolito M, Mutti L, Giannicola R, Pirtoli L, Giordano A, Labate D, Macheda S, Carabetta N, Abdelwahed YS, Landmesser U, Tassone P, Tagliaferri P, De Rosa S, Torella D.
Panuccio G, et al. Among authors: tassone p.
Basic Res Cardiol. 2024 Sep 3. doi: 10.1007/s00395-024-01077-7. Online ahead of print.
Basic Res Cardiol. 2024.
PMID: 39225869
Review.